<!DOCTYPE html>
<html lang="en">

<head>

    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta name="description" content="Power Ten Ventures">
    <meta name="author" content="Craig Gomulka">

    <title>Power Ten Ventures&nbsp;|&nbsp;Redefining Healthcare</title>

    <!-- Bootstrap Core CSS -->
    <link href="css/bootstrap.min.css" rel="stylesheet">

    <!-- Custom CSS -->
    <!--  <link href="css/scrolling-nav.css" rel="stylesheet">  -->

    <!-- Parallax CSS styles -->
    <link href="css/style.css" rel="stylesheet" />

    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
        <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
        <script src="https://oss.maxcdn.com/libs/respond.js/1.4.2/respond.min.js"></script>
    <![endif]-->
</head>

<!-- The #page-top ID is part of the scrolling feature - the data-spy and data-target are part of the built-in Bootstrap scrollspy function -->

<body id="page-top" data-spy="scroll" data-target=".navbar-fixed-top">

    <!-- Navigation -->
    <nav class="navbar navbar-default navbar-fixed-top" role="navigation">
        <div class="container">
            <div class="navbar-header page-scroll">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-ex1-collapse">
                    <span class="sr-only">Toggle navigation</span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
                <a href="#page-top"><img src="images/logo-header-trans-spc.png" alt="" /></a>
            </div>

            <!-- Collect the nav links, forms, and other content for toggling -->
            <div class="collapse navbar-collapse navbar-ex1-collapse">
                <ul class="nav navbar-nav">
                    <!-- Hidden li included to remove active class from about link when scrolled up past about section -->
                    <li class="hidden">
                        <a class="page-scroll" href="#page-top"></a>
                    </li>
                    <li><a class="page-scroll" href="#home">Home</a></li>
                    <li><a class="page-scroll" href="#about">About</a></li>
                    <li><a class="page-scroll" href="#portfolio">Portfolio</a></li>
                    <li><a class="page-scroll" href="#team">Team</a></li>
                    <li><a class="page-scroll" href="#partners">Partners</a></li>
                    <li><a class="page-scroll" href="#locations">Contact</a></li>
                </ul>
            </div>
            <!-- /.navbar-collapse -->
        </div>
        <!-- /.container -->
    </nav>

  <!-- ////////////// Parallax ////////////// -->

  <!-- Home -->
  <div id="home" class="header">
    <div class="home-text">
      <h1>Power Ten Ventures</h1>
      <h4>Redefining Healthcare</h4>
      <a href="#about" class="btn btn-default btn-lg page-scroll">Continue</a>
    </div>
  </div>
  <!-- /Home  -->

  <!-- About -->
  <div id="about" class="pad-section">
    <div class="container">
      <div class="row">
        <div class="col-sm-6 flex-center-vertically">
          <img src="images/logo.png" alt="" />
        </div>
        <div class="col-sm-6 text-center flex-center-vertically">
          <h2>A new breed of private investment firm</h2>
          <p class="lead">We focus on strategic relationships that generate proprietary opportunities for creating, investing, and acquiring high potential companies in the therapeutic medical device, medical service, and healthcare information technology markets.</p>
        </div>
      </div>
    </div>
  </div>
  <!-- /About -->

  <!-- About - What is Power Ten -->
  <div id="whatis" class="pad-section parallax">
    <div class="container">
      <div class="row">
        <div class="col-sm-6">
          <div class="panel panel-default">
            <div class="panel-heading">
              <h2 class="panel-title">What is Power Ten?</h2>
            </div>
            <div class="panel-body lead">
              <p>In rowing, Power Ten is an order by the coxswain for the crew to go to maximum effort to achieve victory.  To our team, Power Ten epitomizes total coordination and focus of our resources and partners to achieve maximum success.</p>
              <p>Power Ten’s mission is to deliver top tier investment returns by investing, creating, and managing a diversified portfolio of market disruptive technologies that can be accelerated via a highly efficient development process to maximize value and minimize risk.</p>
              <p>We believe that building and leveraging strong partnerships is the optimal way to create sustainable and valuable health technology companies</p>
            </div>
          </div>
        </div>
        <div class="col-sm-6">
          <div class="panel panel-default">
            <div class="panel-heading">
              <h2 class="panel-title">Our Philosophy</h2>
            </div>
            <div class="panel-body lead">
              <ul>
                <li>Be Focused – Focus on investments in disruptive technologies that meet large pains in the market via early and growth stage opportunities, as well as licensing from world leading entrepreneurs and scientists.</li>
                <li>Seek Leverage – Use our strategic partner network to validate feasibility, technology development, regulatory pathway, and market push-pull to achieve investment validation and success.</li>
                <li>Drive to the Finish – Provide direction, knowledge, and guidance to our companies through our strategic resources to achieve maximum efficiency to realize our investment goals.</li>
              </ul>
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <!-- /About - What is Power Ten -->


  <!-- Portfolio -->
  <div id="portfolio" class="pad-section portfolio">
      <h2 class="text-center">Portfolio Companies</h2>
      <div id="myCarousel" class="carousel slide" data-ride="carousel">
          <!-- Carousel indicators -->
          <ol class="carousel-indicators">
              <li data-target="#myCarousel" data-slide-to="0" class="active"></li>
              <li data-target="#myCarousel" data-slide-to="1"></li>
              <li data-target="#myCarousel" data-slide-to="2"></li>
              <li data-target="#myCarousel" data-slide-to="3"></li>
              <li data-target="#myCarousel" data-slide-to="4"></li>
              <li data-target="#myCarousel" data-slide-to="5"></li>
          </ol>
          <!-- Wrapper for carousel items -->
          <div class="carousel-inner">
              <div class="item active">
                  <a href="https://www.linkedin.com/company/bluewind-medical" target="_blank"><img src="images/logo-bluewind.png" alt="BlueWind Medical">
                  <p>BlueWind Medical is developing a novel wireless neuro-stimulation platform for the treatment of various clinical indications such as Peripheral Neuropathic Pain (PNP) and Over Active Bladder (OAB)</p></a>
              </div>
              <div class="item">
                  <a href="http://www.glusensemedical.com" target="_blank"><img src="images/logo-glusense.png" alt="GluSense">
                  <p>GluSense is developing an accurate, long-term, minimally invasive, implantable, continuous glucose sensor for diabetes patients.</p></a>
              </div>
              <div class="item">
                  <a href="http://www.maxillent.com" target="_blank"><img src="images/logo-maxillent.png" alt="Maxillent">
                  <p>Maxillent is developing an innovative, minimally invasive, sinus lift implant.</p></a>
              </div>
              <div class="item">
                  <a href="http://www.slenderm.com" target="_blank"><img src="images/logo-slender.png" alt="Slender Medical">
                  <p>Slender Medical is developing a novel treatment for subdermal tissues using non-invasive high intensity focused ultrasound (HIFU).  Treatment indications include aesthetic fat reduction, specifically designed for small body areas such as the chin, as well as medical indications such as treatment of lipoma and keloids.</p></a>
              </div>
              <div class="item">
                  <a href="https://www.helplightning.com" target="_blank"><img src="images/logo-helplightning.png" alt="Help Lightning">
                  <p>Help Lightning has completely reimagined how businesses, customers and employees are able to give and receive help using mobile merged reality video.</p></a>
              </div>
              <div class="item">
                  <a href="http://www.rainbowmd.com" target="_blank"><img src="images/logo-rainbow.jpg" alt="Rainbow Medical">
                  <p>Rainbow Medical is an innovation and investment house focused on the invention, creation, and monetization of proprietary medical technologies that solve major health challenges and revolutionize patient care.</p></a>
              </div>
          </div>
          <!-- Carousel controls -->
          <a class="carousel-control left" href="#myCarousel" data-slide="prev">
              <span class="glyphicon glyphicon-chevron-left"></span>
          </a>
          <a class="carousel-control right" href="#myCarousel" data-slide="next">
              <span class="glyphicon glyphicon-chevron-right"></span>
          </a>
      </div>
  </div>
  <div id="portfolio" class="pad-section">
      <h2 class="text-center">Portfolio News</h2>
      <div class="container news">

        <div class="row">
          <div class="col-sm-12">
            <a href="https://globenewswire.com/news-release/2017/08/15/1084782/0/en/Vascular-Dynamics-Announces-FDA-Approval-to-Initiate-CALM-2-Trial-for-MobiusHD-System-for-the-Treatment-of-Resistant-Hypertension.html" target="_blank">
              Aug 15, 2017
              <h4>
                Vascular Dynamics Announces FDA Approval to Initiate CALM 2 Trial for MobiusHD® System for the Treatment of Resistant Hypertension
              </h4>
              Vascular Dynamics, Inc., (VDI) a privately held medical device company developing novel solutions for the treatment of hypertension, today announces that the United States Food and Drug Administration (FDA) has approved the company’s Investigational Device Exemption (IDE) application to initiate its pivotal trial for its MobiusHD® System for the treatment of resistant hypertension.
            </a>
          </div>
        </div>
        <hr />

        <div class="row">
          <div class="col-sm-12">
            <a href="https://www.israel21c.org/a-simple-israeli-invention-to-treat-resistant-hypertension/" target="_blank">
              Apr 27, 2017
              <h4>
                A simple Israeli invention to treat resistant hypertension
              </h4>
              Vascular Dynamics is in pre-market trials for MobiusHD, an implantable device that tricks the body into modulating blood pressure on its own.
            </a>
          </div>
        </div>
        <hr />

        <div class="row">
          <div class="col-sm-12">
            <a href="http://fieldservicenews.com/technology-spotlight-mobile-merged-reality/" target="_blank">
              Feb 23, 2017
              <h4>
                Technology spotlight: Mobile Merged Reality
              </h4>
              We look at what Help Lightning are terming Mobile Merged Reality, An innovative mobile solution goes beyond augmented reality (AR) to redefine the future of help.
            </a>
          </div>
        </div>
        <hr />

        <div class="row">
          <div class="col-sm-12">
            <a href="http://www.jdrf.org/press-releases/glusense-receives-investment-jdrf-t1d-fund/" target="_blank">
              Feb 15, 2017
              <h4>
                GluSense Receives Investment from JDRF T1D Fund
              </h4>
              GluSense Ltd., a medical device company developing a long lasting injectable glucose sensor for treatment of type 1 diabetes (T1D), today announced it has received an investment from the JDRF T1D Fund, a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial programs.
            </a>
          </div>
        </div>
        <hr />

        <div class="row">
          <div class="col-sm-12">
            <a href="http://www.fiercebiotech.com/medical-devices/rainbow-medical-s-glusense-picks-up-2m-for-injectable-glucose-sensor" target="_blank">
              Feb 15, 2017
              <h4>
                GluSense picks up $2M for injectable glucose sensor
              </h4>
              GluSense, which is developing a long-term glucose-monitoring implant, has received approximately $1.9 million from the newly launched JDRF T1D Fund, according to a spokesman. The company will use the funds to advance its continuous glucose monitoring toward human trials.
            </a>
          </div>
        </div>
        <hr />

        <div class="row">
          <div class="col-sm-12">
            <a href="http://www.vasculardynamics.com/press_release/vascular-dynamics-announces-expedited-access-pathway-designation-by-fda-for-mobiushd/" target="_blank">
              Feb 4, 2017
              <h4>
                Vascular Dynamics Announces Expedited Access Pathway Designation by FDA for MobiusHD
              </h4>
              Vascular Dynamics, Inc., (VDI) a privately held medical device company developing novel solutions for the treatment of hypertension, today announces that the United States Food and Drug Administration (FDA) has approved the company’s application to participate in the Expedited Access Pathway (EAP) program for its MobiusHD® device for the treatment of resistant hypertension.
            </a>
          </div>
        </div>
        <hr />

        <div class="row">
          <div class="col-sm-12">
            <a href="http://www.dailymail.co.uk/health/article-3839650/What-relief-Ankle-bracelet-worn-just-hours-day-help-millions-people-tackle-desperate-need-go.html" target="_blank">
              Oct 15, 2016
              <h4>
                Ankle bracelet worn just a few hours a day could help millions of people tackle that desperate need to go
              </h4>
              A bracelet worn round the ankle for just a few hours a day could help millions of people reduce the frustration of having to make frequent trips to the lavatory. The minimally invasive device works by stimulating a nerve that runs down the leg and can be highly effective for people who have an overactive bladder (OAB).
            </a>
          </div>
        </div>
        <hr />

        <div class="row">
          <div class="col-sm-12">
            <a href="http://www.prnewswire.com/news-releases/bluewind-medical-announces-ce-mark-for-the-bluewind-vivendi-miniature-implanted-wireless-stimulator-to-treat-peripheral-pain-592554011.html" target="_blank">
              Sep 7, 2016
              <h4>
                BlueWind Medical Announces CE-Mark for the BlueWind VIVENDI™ Miniature Implanted Wireless Stimulator to Treat Peripheral Pain
              </h4>
              BlueWind Medical, developer of a miniature wireless neurostimulation platform to treat multiple clinical indications, announced today that the company has received CE-Mark for the BlueWind's VIVENDI miniature wireless neurostimulator to treat Peripheral Neuropathic Pain (PNP). This is the second product BlueWind has received CE-Mark based on its advanced neurostimulation platform, after obtaining few months ago CE-Mark for treatment of an Over Active Bladder.
            </a>
          </div>
        </div>
        <hr />

        <div class="row">
          <div class="col-sm-12">
            <a href="http://www.prnewswire.com/news-releases/bluewind-medical-announces-ce-mark-for-the-first-in-the-world-miniature-wireless-neurostimulator-to-treat-overactive-bladder-583087221.html" target="_blank">
              Jun 15, 2016
              <h4>
                BlueWind Medical Announces CE-Mark for the First in the World Miniature Wireless Neurostimulator to Treat Overactive Bladder
              </h4>
              Bluewind Medical, developer of a miniature wireless neurostimulation platform to treat multiple clinical indications, announced today that the company has received CE-Mark for its OAB-1000 System, the first in the world miniature wireless neurostimulator to treat Overactive Bladder (OAB).
            </a>
          </div>
        </div>
        <hr />

        <div class="row">
          <div class="col-sm-12">
            <a href="http://www.massdevice.com/nuvasive-co-founder-mckinley-vascular-dynamics-new-coo-personnel-moves-june-9-2016/" target="_blank">
              Jun 9, 2016
              <h4>
                NuVasive co-founder McKinley is Vascular Dynamics new COO
              </h4>
              Vascular Dynamics said it tapped NuVasive Inc. (NSDQ:NUVA) co-founder and former CEO James McKinley as its new chief operating officer. McKinley has held leadership positions at Advent Medical, Endosphere, Farallon Medical and Nellix, as well as NuVasive.
            </a>
          </div>
        </div>
        <hr />

        <div class="row">
          <div class="col-sm-12">
            <a href="http://www.prnewswire.com/news-releases/bluewind-medical-announces-successful-completion-of-patients-enrolment-for-its-overactive-bladder-oab-clinical-study-toward-a-ce-mark-564844101.html" target="_blank">
              Jan 11, 2016
              <h4>
                BlueWind Medical Announces Successful Completion of Patients' Enrolment for Its Overactive Bladder (OAB) Clinical Study Toward a CE Mark
              </h4>
              BlueWind Medical, developer of a wireless neuro-stimulation device to treat multiple clinical indications, such as back pain, peripheral neuropathic pain, incontinence (OAB), epilepsy, and more, announced today the completion of patient enrolment for an Overactive Bladder (OAB) study which is currently being conducted to support CE Mark submission. Thirty-six patients were successfully enrolled in four medical centres in the Netherlands and the United Kingdom.
            </a>
          </div>
        </div>
        <hr />

        <div class="row">
          <div class="col-sm-12">
            <a href="http://www.prnewswire.com/news-releases/bluewind-medical-announces-successful-completion-of-patients-follow-up-for-its-peripheral-neuropathic-pain-pnp-study-toward-a-ce-mark-546560522.html" target="_blank">
              Nov 12, 2015
              <h4>
                BlueWind Medical Announces Successful Completion of Patients' Follow-Up for its Peripheral Neuropathic Pain (PNP) Study Toward a CE Mark
              </h4>
              BlueWind Medical, developer of the "Reprieve" wireless neuro-stimulation device to treat multiple clinical indications, such as pain management, incontinence (OAB), epilepsy, sleep-apnea and more, announced today the completion of patient follow up for a peripheral neuropathic pain (PNP) study for its CE submission. The study was successfully performed in four centers in Belgium and Poland with up to six months follow-up. Study results will be presented next month at the North American Neurostimulation Society (NANS) annual meeting in Las Vegas.
            </a>
          </div>
        </div>
        <hr />

        <div class="row">
          <div class="col-sm-12">
            <a href="http://www.cbsnews.com/news/google-glass-surgeons-new-best-friend-what-one-surgeon-is-saying-about-tech/" target="_blank">
              Dec 25, 2013
              <h4>
                Google Glass surgeon's new best friend? What one surgeon is saying about tech
              </h4>
              At the University of Alabama-Birmingham, orthopedic surgeon, Dr. Brent Ponce, prepared for a shoulder replacement. Behind his face shield he wore Google Glass -- the wearable computer. On one day, Ponce and Dantuluri were testing Google Glass paired with VIPAAR, a videoconferencing platform that allows users to interact with the picture.
            </a>
          </div>
        </div>
        <hr />

        <div class="row">
          <div class="col-sm-12">
            <a href="http://www.uab.edu/news/latest/item/3896-uab-does-virtual-surgery-with-vipaar-and-google-glass" target="_blank">
              Oct 28, 2013
              <h4>
                UAB does virtual surgery with VIPAAR and Google Glass
              </h4>
              A University of Alabama at Birmingham surgical team has performed one of the first surgeries using a virtual augmented reality technology from VIPAAR in conjunction with Google Glass, a wearable computer with an optical head-mounted display. The combination of the two technologies could be an important step toward the development of useful, practical telemedicine.
            </a>
          </div>
        </div>
        <hr />

        <div class="row">
          <div class="col-sm-12">
            <a href="http://www.prnewswire.com/news-releases/iraise-sinus-lift-system-launched-in-france-belgium-and-luxembourg-209911151.html" target="_blank">
              Jun 3, 2013
              <h4>
                iRaise Sinus Lift System Launched in France, Belgium and Luxembourg
              </h4>
              Maxillent Ltd., provider of the iRaise™ Sinus Lift System, the revolutionary minimally-invasive solution for sinus lift procedures, has signed an exclusive contract with Dental Force, a distribution company focused on premium dental solutions, to distribute the iRaise in France, Belgium and Luxembourg.
            </a>
          </div>
        </div>
        <hr />

        <div class="row">
          <div class="col-sm-12">
            <a href="http://www.bizjournals.com/birmingham/news/2013/03/11/vipaar-grows-service.html" target="_blank">
              Mar 11, 2013
              <h4>
                VIPAAR expands services to IPads, smartphones
              </h4>
              A Birmingham-based company that has developed a technology to assist remote clients has made its product accessible on smartphones and Apple iPads. Drew Deaton, CEO of VIPAAR, based at business incubator the Innovation Depot, said his company made its product widely available on an app about two months ago.
            </a>
          </div>
        </div>
        <hr />

        <div class="row">
          <div class="col-sm-12">
            <a href="http://www.prnewswire.com/news-releases/maxillents-iraise-the-sinus-lift-implant-introduced-into-the-hong-kong-market-169157966.html" target="_blank">
              Sep 10, 2012
              <h4>
                Maxillent's iRaise™, the Sinus Lift Implant, Introduced Into the Hong Kong Market
              </h4>
              Maxillent Ltd., a company dedicated to innovative solutions for dental implants, has signed an exclusive contract with Pioneer Richteeth Medical Distribution Company Shanghai Ltd. for the distribution of the iRaise™ Sinus Lift Implant in Hong Kong.
            </a>
          </div>
        </div>

      </div>
  </div>
  <!-- /Portfolio -->


  <!-- Team -->
  <div id="team" class="pad-section team">
    <div class="container">
      <h2 class="text-center">Our Team</h2> <hr />
      <div class="row">
        <div class="col-sm-12">
          <div class="role">
            <div>
              <h2 class="role-title">Management</h2>
            </div>
          </div>
        </div>
      </div>
      <div class="row">
        <div class="col-sm-12">
          <div class="panel panel-default">
            <div class="panel-heading">
              <h2 class="panel-title">Norman Stapleton</h2>
            </div>
            <div class="panel-body lead">
Norman Stapleton is the founder of Power Ten Ventures.  He serves as Managing Partner for Power Ten Medical Ventures I, LP, the predicate fund to Power Ten Ventures II, LP.  Norman is a former naval officer serving as an engineering officer onboard USS Champion (MCM-4).  After transitioning out of the military, Mr. Stapleton worked in management positions at International Paper, PSDI, and Texas Instruments.  While at Texas Instruments, Norman was Director of Medical Strategy and was the architect of TI’s largest equity investment into a private entity which led to the establishment of TI’s medical business unit.  In 2007, Norman left TI and began consulting in Israel for medical device startups, and was integral in the establishment of Rainbow Medical, Ltd., Israel’s leading medical device development company, where he serves on the Investment Committee.  In 2010, Norman launched Power Ten Medical Ventures I, LP, which has already attained a substantial return on investment for its limited partners.
<br><br>Norman is a 1991 and 1992 Intercollegiate Rowing Association Champion.  He is a member of the  U.S. Naval Academy Athletic Hall of Fame with the 1992 Varsity Heavyweight Eight.  He was also awarded the 1992 Rusty Callow trophy which is given to that member of the Varsity Heavyweight Crew who contributed most to the team’s determination, competitive desire, and willingness to sacrifice.
<br><br>Norman holds a Bachelor of Science degree from the United States Naval Academy, a Master of Business Administration from Carnegie Mellon University, and a Master of Engineering in Biomedical Engineering from Cornell University.
            </div>
          </div>
        </div>
      </div>
      <div class="row">
        <div class="col-sm-12">
          <div class="panel panel-default">
            <div class="panel-heading">
              <h2 class="panel-title">Craig Gomulka</h2>
            </div>
            <div class="panel-body lead">
Craig has been a venture investor in healthcare and technology for over 16 years and currently serves as a Venture Partner and advisor for Power Ten Ventures. Most recently Craig served as Vice President of Strategic Investments at Highmark Health and as Managing Director of Highmark Ventures, where he led Highmark’s corporate venture capital efforts. Before joining Highmark, Craig served as the Chief Investment Officer of Innovation Works, a Pittsburgh-based development fund where he executed over 60 new investments and follow-on financings and managed through 12 portfolio company acquisitions. Prior to Innovation Works, Craig was a Director and Partner with Draper Triangle Ventures, an early stage healthcare and IT focused venture capital firm with $185M under management. Craig has served on the boards of Axial Healthcare, BitArmor Systems (acq. by Trustwave), Imago Scientific (acq. by AMETEK), and Hypernex (acq. by Nova Measuring Instruments, Inc. (NASDAQ: NVMI)), and as a board observer for Acclaris (acq. by Towers Watson) and Array Health Solutions.
<br><br>Prior to joining Draper Triangle, Craig worked for Intel Corporation where he built supplier pricing software and with RRZ Investment Management as a software developer, designing and programming fixed income and equity trading software and algorithms.
<br><br>Craig received his B.A. from Colgate University. Craig achieved his MBA from Carnegie Mellon University Tepper School of Business in May of 2000 and was awarded the Chartered Financial Analyst (CFA) designation in September of 2000.
            </div>
          </div>
        </div>
      </div>
      <div class="row">
        <div class="col-sm-12">
          <div class="role">
            <div>
              <h2 class="role-title">Advisors</h2>
            </div>
          </div>
        </div>
      </div>
      <div class="row">
        <div class="col-sm-12">
          <div class="panel panel-default">
            <div class="panel-heading">
              <h2 class="panel-title">Marie Csete MD, PhD</h2>
            </div>
            <div class="panel-body lead">
Dr. Csete is a Scientific Advisor to Power Ten Ventures. Marie received her undergraduate music degree from Princeton University, followed by an MD from Columbia University, College of Physicians & Surgeons.  She is board certified in Anesthesiology with subspecialty certification in Critical Care.  Her academic career focused on optimizing the perioperative management of liver transplant patients, and she led the liver transplant anesthesiology services at UCSF, UCLA, Michigan and Emory where she was co-director of the MD/PhD program and founding director of the Emory/GaTech human embryonic stem cell core facility.  Mid-career Dr. Csete received a PhD in developmental biology from Caltech.  Her PhD work focused on the role of oxygen in stem cell fate, which led to later work in stem cell aging.  Dr. Csete was the first CSO of CIRM, the California state stem cell agency where she supervised development of its core programs.  Currently President & Chief Scientist of the non-profit Huntington Medical Research Institutes, her lab studies iPS models of neurodegeneration.  At HMRI she is leading a new scientific strategic plan focused on multidisciplinary approaches to common diseases with core emphasis on inflammation and metabolism, and development of new imaging approaches to quantify these processes.   She also serves as Associate Medical Director of Clinical Research at Huntington Memorial Hospital, Professor of Anesthesiology at Keck USC School of Medicine and Visiting Associate, Caltech Medical Engineering.
            </div>
          </div>
        </div>
      </div>
      <div class="row">
        <div class="col-sm-12">
          <div class="panel panel-default">
            <div class="panel-heading">
              <h2 class="panel-title">Farrell O. Mendelsohn, M.D.</h2>
            </div>
            <div class="panel-body lead">
Dr. Farrell Mendelsohn is one of the nation’s leading interventional  cardiologist and serves as a Scientific Advisor to Power Ten Ventures.  He is a partner at Cardiology, PC at the Princeton Heart and Vascular Center in Birmingham, Alabama where he directs the cardiovascular research programs, which includes one of the nation’s leading research sites in the United States for regenerative medicine studies.  Dr. Mendelsohn also directs one of the nation’s leading carotid stent programs which has treated more patients that any other program in the Southeast with one of the lowest complication rates in the nation.  He currently manages the first in man research study for Vascular Dynamics’ MobiusHD® device, a catheter-delivered carotid implant designed for the treatment of drug resistant hypertension.
<br><br>Dr. Mendelsohn graduated from Johns Hopkins University School of Medicine and completed his internship and residency at Massachusetts General Hospital.  While completing his residency, Dr. Mendelsohn served as a clinical instructor in internal medicine at Harvard Medical School.  Dr. Mendelsohn completed a fellowship at Duke University Medical Center in clinical and interventional cardiology with a specialization in the management of patients with vascular disease.  He was selected as the first Joseph C. Greenfield, Jr. Scholar in Interventional Cardiology.  Dr. Mendelsohn has published articles on carotid, renal, and peripheral arterial stenting and has presented on these topics at national and international scientific meetings.  Dr. Mendelsohn has also been extensively involved in the design and development of coronary and catheter-based systems, including the development of the Vessix Renal Denervation system at Boston Scientific where he also serves on the Renal Denervation Scientific Advisory Board.  Dr. Mendelsohn is the Chief Medical Officer for InnoMed Scientific in Shanghai, China where he also co-founded Gateway Medical, which was the first pre-clinical commercial laboratory in Asia researching and developing medical device technologies.
<br><br>Dr. Mendelsohn is Board Certified in Cardiovascular Disease and Interventional Cardiology, Vascular Medicine and Endovascular Medicine.  Dr. Mendelsohn is a Fellow of the American College of Cardiology, as well as a member of the Jefferson County Medical Society, the Alabama Medical Association, and the Baptist Health System Foundation Board.
            </div>
          </div>
        </div>
      </div>
    </div>
  </div>
  <!-- /Team -->


  <!-- Partners -->
  <div id="partners" class="pad-section">
    <div class="container-fluid">
      <h2 class="text-center">Our Partners</h2> <hr />
      <div class="row text-center">
        <div class="col-sm-1">
        </div>
        <div class="col-sm-4">
          <img src="images/logo-rainbow.jpg" alt="Rainbow Medical" />
          <h4>Rainbow Medical</h4>
          <p>Rainbow Medical is an innovation and investment house focused on the invention, creation, and monetization of proprietary medical technologies that solve major health challenges and revolutionize patient care. By addressing significant unmet market needs, Rainbow Medical seeks to generate exceptional returns for its investors.</p>
        </div>
        <div class="col-sm-2">
        </div>
        <div class="col-sm-4">
          <img src="images/logo-litgp.jpg" alt="LITG" />
          <h4>Long Island Technology Group</h4>
          <p>The mission of LITG is to be an incubator allowing young talent to investigate, explore and develop enabling technology for the purpose of solving real-life business problems, adding value to companies and customers.</p>
        </div>
        <div class="col-sm-1">
        </div>
      </div>
    </div>
  </div>
  <!-- /Partners -->


  <!-- Locations -->
  <div id="locations" class="pad-section locations">
    <div class="container-fluid">
      <div class="row text-center">
        <!--  <div class="col-md-4">
          <h1>Boulder</h1>
        </div> -->
        <div class="col-md-6">
          <h1>Birmingham</h1>
        </div>
        <div class="col-md-6">
          <h1>Tel Aviv</h1>
        </div>
      </div>
    </div>
  </div>
  <!-- /Locations -->


  <!-- Contact -->
  <div id="contact" class="pad-section">
    <div class="container">
      <div class="row text-center">
        <div class="col-md-12">
          <h3 class="text-center">Contact Us</h3>
          <h4 class="text-center"><a href="mailto:info@powertenvc.com">info@powertenvc.com</a></h4>
        </div>
      </div>
    </div>
  </div>
  <!-- /Contact -->

    <!-- footer -->
    <footer>
      <hr />
      <div class="container">
        <p class="text-right">Copyright &copy; Power Ten Ventures 2017</p>
      </div>
    </footer>
    <!-- /footer -->

    <!-- jQuery -->
    <script src="js/jquery.js"></script>

    <!-- Bootstrap Core JavaScript -->
    <script src="js/bootstrap.min.js"></script>

    <!-- Scrolling Nav JavaScript -->
    <script src="js/jquery.easing.min.js"></script>
    <script src="js/scrolling-nav.js"></script>
    <!-- Parallax JavaScripts -->
      <!-- <script src="js/jquery-1.10.2.js"></script> -->
    <script src="js/main.js"></script>

</body>

</html>
